Alkem Laboratories Limited has informed the Exchange regarding a press release dated March 13, 2025, titled "US FDA Inspection at Company s Bioequivalence Center located at Taloja".
Alkem Laboratories Limited has informed the Exchange regarding a press release dated March 13, 2025, titled "US FDA Inspection at Company s Bioequivalence Center located at Taloja".